Tianhong Shengjie Completes $12 Million Financing for Medical Devices

Tianhong Shengjie, a Suzhou company developing medical devices for venous diseases, completed a $12 million Series B financing. Founded in 2016, Tianhong Shengjie claims to be the first China novel medical device company developing interventional devices with independent IP. In five years, the company has registered four products for use in China . New investors in the round include Guolian Investment, Lotus Lake Ventures, Purple Bell Startups and Ningbo Kangtuo. More details.... Share this with colleagues: // //